Haifa, Israel

Julia Kaftanov


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Hafia, IL (2007)
  • Haifa, IL (2006 - 2010)

Company Filing History:


Years Active: 2006-2010

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Julia Kaftanov: Innovator in Pharmaceutical Chemistry

Introduction

Julia Kaftanov is a prominent inventor based in Haifa, Israel, known for her significant contributions to pharmaceutical chemistry. With a total of eight patents to her name, she has made remarkable advancements in the synthesis of important pharmaceutical compounds.

Latest Patents

Among her latest patents is the innovative method for the synthesis of irbesartan. This patent outlines a process that utilizes a Suzuki coupling reaction along with a novel intermediate, specifically 2-butyl-3-(4'-bromobenzyl)-1,3-diazaspiro[4.4]non-1-ene-4-one. The process includes a crucial step of reacting this intermediate with a protected imidazolephenylboronic acid. Another notable patent involves the development of amorphous and crystalline forms of losartan potassium. This invention details novel amorphous losartan potassium and various crystalline forms, including hydrates and solvates, along with processes for their preparation and their applications in medicine.

Career Highlights

Julia Kaftanov is currently employed at Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. Her work focuses on the development of innovative drug formulations and processes that enhance the efficacy and safety of medications.

Collaborations

Throughout her career, Julia has collaborated with esteemed colleagues such as Gennady Nisnevich and Igor Rukhman. These partnerships have contributed to her success in the field of pharmaceutical research and development.

Conclusion

Julia Kaftanov stands out as a key figure in pharmaceutical innovation, with her patents reflecting her expertise and dedication to advancing medical science. Her contributions continue to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…